Cumberland Pharmaceuticals Inc
2013 Q4 - 2026 Q2 (29 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q2 | 8/14/2026 | 170 | 0.0% | 26,200 | 6/30/2026 |
| 2026 Q1 | 5/15/2026 | 531 | 0.0% | 163,468 | 3/31/2026 |
| 2025 Q4 | 2/17/2026 | 651 | 0.0% | 163,468 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 588 | 0.0% | 188,355 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 631 | 0.0% | 188,355 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 779 | 0.0% | 184,155 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 436 | 0.0% | 184,155 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 367 | 0.0% | 286,655 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 439 | 0.0% | 286,655 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 482 | 0.0% | 286,655 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 499 | 0.0% | 286,655 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 542 | 0.0% | 286,655 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 421 | 0.0% | 286,655 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 559 | 0.0% | 286,655 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 645 | 0.0% | 286,655 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 691 | 0.0% | 286,655 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 595 | 0.0% | 286,655 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 808 | 0.0% | 286,655 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 1,103 | 0.0% | 236,255 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 435 | 0.0% | 160,987 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 436 | 0.0% | 153,387 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 473 | 0.0% | 156,187 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 445 | 0.0% | 151,287 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 587 | 0.0% | 183,000 | 9/30/2020 |
| 2020 Q2 | 8/31/2020 | 609 | 0.0% | 183,000 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 664 | 0.0% | 183,000 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 942 | 0.0% | 183,000 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 378 | 0.0% | 84,000 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 429 | 0.0% | 84,000 | 12/31/2013 |